PepGen Inc. (NASDAQ:PEPG) Insider Michelle L. Mellion Sells 9,260 Shares

PepGen Inc. (NASDAQ:PEPG) insider Michelle L. Mellion sold 9,260 shares of the stock in a transaction on Monday, June 24th. The shares were sold at an average price of $18.19, for a total value of $168,439.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Michelle L. Mellion also recently made the following trade(s):

• On Tuesday, June 11th, Michelle L. Mellion sold 500 shares of PepGen stock. The stock was sold at an average price of $18.04, for a total transaction of $9,020.00.

PepGen Trading Down 2.7 %

NASDAQ PEPG opened at $16.46 on Friday. The business’s fifty day moving average is $14.92 and its 200-day moving average is $12.39. PepGen Inc. has a one year low of $3.72 and a one year high of $18.72.

PepGen (NASDAQ:PEPG) last released its earnings results on Tuesday, May 14th. The company reported ($0.63) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.11. Equities analysts predict that PepGen Inc. will post -2.87 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on PEPG. Wedbush restated an “outperform” rating and set a $20.00 price target on shares of PepGen in a report on Wednesday, May 15th. HC Wainwright restated a “buy” rating and issued a $26.00 target price on shares of PepGen in a research note on Wednesday, May 15th.

Hedge Funds Weigh In On PepGen

Several large investors have recently modified their holdings of the business. Adage Capital Partners GP L.L.C. boosted its holdings in PepGen by 18.3% in the 3rd quarter. Adage Capital Partners GP L.L.C. now owns 680,000 shares of the company’s stock worth $3,454,000 after buying an additional 105,000 shares during the period. Vanguard Group Inc. lifted its position in shares of PepGen by 68.0% during the first quarter. Vanguard Group Inc. now owns 850,445 shares of the company’s stock worth $12,502,000 after acquiring an additional 344,266 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in shares of PepGen by 18.1% in the first quarter. Janus Henderson Group PLC now owns 1,166,642 shares of the company’s stock worth $17,225,000 after acquiring an additional 178,438 shares during the period. Acadian Asset Management LLC purchased a new position in shares of PepGen in the first quarter valued at $30,000. Finally, RA Capital Management L.P. raised its stake in shares of PepGen by 31.5% during the 1st quarter. RA Capital Management L.P. now owns 10,689,545 shares of the company’s stock valued at $157,136,000 after purchasing an additional 2,557,593 shares during the period. Hedge funds and other institutional investors own 58.01% of the company’s stock.

About PepGen

PepGen Inc, a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients.